Kymera Therapeutics (KYMR) Liabilities and Shareholders Equity (2019 - 2026)
Kymera Therapeutics (KYMR) reported Liabilities and Shareholders Equity of $1.65 billion for Q2 2026, up 45.5% from $1.13 billion a year earlier but down 1.4% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Kymera Therapeutics posted Liabilities and Shareholders Equity of $1.74 billion, up 78.2% from FY2024.
- Liabilities and Shareholders Equity has a five-year compound annual growth rate of 29.0% (FY2020 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $978.04 million in FY2024 (+69.9%), $575.76 million in FY2023 (-4.5%), $603.13 million in FY2022 (-0.5%) and $605.91 million in FY2021 (+24.4%).
- Five-year quarterly Liabilities and Shareholders Equity spans a low of $523.42 million in Q2 2022 and a high of $1.74 billion in Q4 2025.
- Year over year, Liabilities and Shareholders Equity has now increased in each of the last ten quarters, with growth averaging 51.5% over the last eight quarters.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was Q3 2024 (growth of 87.3%); the low point was Q3 2023 (a decline of 13.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.67 billion (Q1 2026), $1.74 billion (Q4 2025) and $1.1 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Kymera Therapeutics | 9.25 Bn | 6.56 Bn | - | 1.65 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.65 Bn |
| Mar 31, 2026 | 1.67 Bn |
| Dec 31, 2025 | 1.74 Bn |
| Sep 30, 2025 | 1.10 Bn |
| Jun 30, 2025 | 1.13 Bn |
| Mar 31, 2025 | 918.31 Mn |
| Dec 31, 2024 | 978.04 Mn |
| Sep 30, 2024 | 1.03 Bn |
| Jun 30, 2024 | 826.02 Mn |
| Mar 31, 2024 | 868.25 Mn |
| Dec 31, 2023 | 575.76 Mn |
| Sep 30, 2023 | 552.38 Mn |
| Jun 30, 2023 | 581.95 Mn |
| Mar 31, 2023 | 613.91 Mn |
| Dec 31, 2022 | 603.13 Mn |
| Sep 30, 2022 | 638.47 Mn |
| Jun 30, 2022 | 523.42 Mn |
| Mar 31, 2022 | 563.06 Mn |
| Dec 31, 2021 | 605.91 Mn |
| Sep 30, 2021 | 642.45 Mn |
API Access
Kymera Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();